Funding from Foundations/Private Sources
JHU's Corporate and Foundation Relations maintains a Web site listing upcoming grant competitions that are sponsored by foundations and other private sources: http://jhuresearch.jhu.edu/OCFR.htm. They are in addition to the limited-submission RFPs periodically announced by the Research Projects Administration office. The opportunities are listed in order of deadline and links to each funder's application information are provided. Contact Karin Hunt (email@example.com) with any questions.
DEADLINE: Monday, January 13, 2014
Application Deadline: January 14, 2014
Mentors will be required to provide a 12-month,
full-time clinical research experience for the student. Students must
be willing to take 12 months out from medical school, typically after
the third year of school. Each Clinical Research Mentorship grant will
consist of $64,800, inclusive of a $29,000 stipend for the student.
The student's year out will start in the summer of 2014 and end in the
summer of 2015.
For more information about this opportunity,
including eligibility requirements, visit the
The Hopkins Conte Digestive Diseases Basic
and Translational Research Core Center was initiated with NIH funding
June 2011. The goal of the Core Center is to advance GI research at
Hopkins by bringing together GI investigators and encouraging others
in the community to enter this area of research. A key component of
this Center is to provide funding for Pilot/Feasibility (P/F) Projects.
These are one year awards of $10,000-$25,000 typically given each year
to ~4 young faculty who are on track to apply for and receive NIH-R01
funding. The proposals are short (3 pages), with biosketch, etc (details
below) and the turn-around is ~3 months.
The order above (1>2>3) represents the priority
for selecting projects for funding. Investigators may receive P/F support
only once in any 5-year period. Funding is for one year, with consideration
for a second year upon submission of a formal application, which must
include a progress report. All recipients of P/F project funding will
be required to submit a yearly update on their progress for 5 years.
Amount and Requirements of P/F Award:
LETTER OF INTENT DUE BY: Monday, February 3rd,
The Johns Hopkins Center for Musculoskeletal
Research has established a program to encourage investigators with expertise
and interest in musculoskeletal disease, promote novel research approaches,
encourage collaboration, raise visibility of musculoskeletal research
at Hopkins, and attract young investigators into the field. This program
provides competitive pilot and feasibility grants in musculoskeletal
research through philanthropic resources acquired by the Department
of Orthopaedic Surgery in the School of Medicine. This special program
provides support for promising investigators with innovative ideas relating
to pathogenic mechanisms, basic science, and therapeutic approaches
related to bone and muscle research.
Funds of $30,000 (direct costs only) for
three one-year pilot studies, with an eligibility to apply for competitive
renewal are available. Junior investigators without current or past
NIH research support OR established investigators who would like to
transition to a new career focus are strongly encouraged to apply. Please
circulate the attached flyer to any faculty or researchers in your division
or department who may be interested in this program. More specific information
is available at: www.hopkinsmedicine.org/musculoskeletal_research
Interested candidates should submit a Letter
of Intent to: CMRGrants@jhmi.edu
no later than 5 p.m. on Monday, February 3rd, 2014.
If there are any questions, please contact
Lynne Jones at 443-444-5906 or firstname.lastname@example.org.
Novo Nordisk is inviting a limited number of leading US academic and medical research institutions to announce this opportunity among those faculty members who could potentially have novel ideas for biologics innovation within diabetes and obesity research. These Awards can be granted to faculty members who enter this competitive process and submit proposals for nonclinical research. Both young and established scientists at invited institutions can apply.
The areas of research in scope of the Science Forum program are:
Non-clinical research related to new biologic therapeutics and targets amenable to biologics therapeutics or novel effects of known biologics in the field of Type 1 Diabetes and Type 2 Diabetes, including micro- and macrovascular complications, and obesity
The term 'biologics' means large peptide or protein ligands (e.g. hormones), inhibitory or modulating antibodies, immunotherapies, micro- and small interfering RNAs , and cell based concepts (e.g. stem cells). Such biologics either have to be novel or represent novel effects of a known entity.
The purpose of these Awards is to foster collaboration with Novo Nordisk R&D and facilitate translation of new ideas from early diabetes and obesity research into innovation by bringing new biologics concepts to a pre-clinical Proof of Principle milestone.
Types of Awards:
Early Exploration: $250,000 (direct research costs only) for a two year period. The Early Exploration Award supports nonclinical research for early-stage hypotheses that do not yet have (or only very limited) preliminary data but show considerable promise for advancing the treatment of diabetes or obesity. This includes target discovery proposals.
Proof of Principle (PoP): $500,000 (direct research costs only) for a two year period. The Proof of Principle (PoP) Award supports nonclinical research for the validation of early stage innovations with sufficient supporting data to conclude on nonclinical PoP studies. In general, PoP studies will require results from experiments in established animal models, in vitro human systems or reduction to practise experiments for protein technologies.
As part of the PoP Award, Applicants have the option to have additional scientific support provided by Novo Nordisk. This may include supervision and counseling by Novo Nordisk senior scientists, custom synthesis of novel biologics (e.g. peptides and proteins), and access to Novo Nordisk marketed protein therapeutics and Novo Nordisk in-house specialized lab equipment and animal models.
Proposals must be submitted no later than February 7, 2014.
Applicants must use the 2 page non-confidential summary form provided by Novo Nordisk and email it to email@example.com.
For more information please contact:
Kristian Tage Hansen, PhD
The American Asthma Foundation (AAF) supports highly innovative research from all fields relevant to asthma. We wish to draw outstanding investigators from other fields into the study of asthma, and most of our investigators are studying asthma for the first time. All grants will be to investigators who are within 10 years of their first independent faculty appointment. Recipients will be designated AAF Scholars.
AWARD AMOUNT: Up to $450,000 ($150,000
per year for up to 3 years.) Funds for institutional overhead are not
APPLICATION DEADLINE: February 12,
START DATE: July 1, 2014
ORGANIZATION: The American Asthma
Foundation is the largest private funder of asthma-related research,
having awarded over $100 million to scientists since 2000.
MISSION: The AAF's mission is to
improve treatments for, prevent, and find a cure for asthma by developing
important new pathways of investigation in basic research regarding
REVIEW CRITERIA: Innovation, research
proposal, relevance to asthma, investigator
NOTE: The application is short (maximum
7 pages). Preliminary data are not required.
FURTHER INFORMATION AT: http://americanasthmafoundation.org/
This $100,000 grant
from the Bay Area Lyme Foundation has just been announced. Important
criteria include demonstrated professional and scientific leadership
in the biomedical sciences, ability to execute, and a strong supporting
scientific rationale for the project. The award recipient will be an
emerging researcher who embodies the future of leadership in Lyme disease
research and has identified a defined approach to improved diagnostics
or therapies for Lyme disease. Applicants must be affiliated with an
academic, research or industry organization. More details and an application
can be found at The full criteria and application for this award can
be found at http://www.bayarealyme.org/research/emerging-leader-award.
Applications will be accepted from researchers throughout the United
States through February 15, 2014.
DEADLINE: Tuesday, February
Reminder that the Damon
Runyon Cancer Research Foundation changed their application process
for 2014 and no longer require institutional nominations. Please see
their website for more details:
Deadline: March 15, 2014
innovative research projects that have the potential to advance the
implementation of personalized treatment for solid tumors are invited
to apply. Potential research topics which could be funded through the
GOI include: Research on molecular biomarkers or new targeted treatments,
technology platforms for the routine analysis of molecular biomarkers,
side effect management and platforms or tools which allow patients to
access individualized treatment.
A total grant of up
to € 1,000,000 will be awarded to one or more selected projects.
Applications will be
evaluated by a Scientific Steering Committee including internationally
renowned oncologists and researchers against the following criteria:
April 1, 2014 Electronic/April 2, 2014 Paper
There are various grants
available - for details see website: http://www.cancer.org/research/applyforaresearchgrant/granttypes/index